Document is current

Article History

Received: 25 February 2024

Accepted: 31 May 2024

First Online: 22 June 2024

Declarations

:

: This study will follow the ethical criteria for medical research involving human subjects of the Declaration of Helsinki and the ethical criteria for medical research of Xijing Hospital during the development of the study. This study was approved by the Ethics Review Committee of Xijing Hospital (No. KY20222292-F-1) and is registered in the Chinese Clinical Trial Registry (No. ChiCTR2300068831: The trial registered in ChiCTR2300068831 is observational research, which contains two parts: a cohort study and a cross-sectional study. The cohort study included 30 individuals with SCI and 30 healthy controls (for a 20% dropout rate), and the cross-sectional study included 33 individuals with SCI. This protocol focused only on cohort studies. All subjects will be required to agree to participate in the study and provide informed consent.

: All the detection personnel and subjects in the figures of this study fully understood the purpose of this research, agreed to appear in the figures of this study, and signed the <i>Consent to Publish Declaration</i>.

: Recruitment started in September 2023 and will continue throughout 2024 for the cohort. By January 17, 2024, 10 patients and 10 healthy controls had agreed to participate in the study.

: The authors have no conflict of interest.